Loading Shopping Cart Items...
FREE FOR MEMBERS!
Sponsored by Siemens Healthineers
Description: Non-alcoholic Fatty Liver Disease (NAFLD) has reached epidemic levels and threatens to overwhelm healthcare systems and specialists. This presentation will introduce you to this disease and the role the Siemens Healthineers Enhanced Liver Fibrosis (ELF™) test plays in non-invasive testing for disease staging and prognosis. It will help you understand the vital role that laboratories play in this process, and how serum markers along with other non-invasive tests are the preferred methods for diagnosis, prognosis, and ongoing surveillance. The presentation will also provide useful information on incorporating the ELF test into your testing menu.
Start date: Upon registration
Completion: Up to 52 weeks
At the end of this webinar you will be able to:
Speaker: H. Roma Levy, MS
Roma Levy is the Clinical Expert for Liver Disease at Siemens Healthineers. In this position, she is responsible for providing global scientific support and education on NAFLD/NASH and hepatocellular carcinoma.
Ms. Levy earned an MS degree in molecular biology at University of California Santa Cruz, where she conducted independent research on the molecular basis of circadian rhythms. As a medical writer for Siemens Healthineers, over the last 18 years she has authored multiple articles, abstracts, posters, and clinical educational presentations in diverse areas, including liver fibrosis, hepatitis, sepsis, COVID-19, oncology, endocrinology, fetal medicine, cardiology, and opioid addiction.
Recorded: May 10, 2023
PEP hours: 1.0
CPS credits: 0
*Note: PEP hours and/or CPS credits will only be awarded upon successful completion of the quiz.
Loading Shopping Cart Items...